Basic Information
| RNALocate ID: | RLID:11000933 |
| RNA Symbol: | hsa-miR-33a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-33a |
| RNA ID: | miRBase:MIMAT0000091 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21505438 |
| Tissue/Cell Line: | Primary dendritic cells|T cell line (J77) |
| Method: | Microarray |
| Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001394 | Cytoplasm | Adjacent normal tissue|GC tissue | 30943047 |
| RLID:01001395 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001396 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001397 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000934 | Exosome | Brain tissue | 23382797 |
| RLID:11000935 | Exosome | Plasma | 23663360 |
| RLID:11000936 | Microvesicle | Plasma | 23077538 |
| RLID-D:11000290 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine | |
| RLID-D:11001158 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-33a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-41634 |
| MNDR | hsa-miR-33a-5p | Oral squamous cell carcinoma | MNDR-E-MI-41635 |
| MNDR | hsa-miR-33a-5p | Medulloblastoma | MNDR-E-MI-41636 |
| MNDR | hsa-miR-33a-5p | Lymphoma | MNDR-E-MI-41637 |
| MNDR | hsa-miR-33a-5p | Lymphoma non-hodgkin | MNDR-E-MI-41638 |
| MNDR | hsa-miR-33a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-41639 |
| MNDR | hsa-miR-33a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-41640 |
| MNDR | hsa-miR-33a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-41641 |
| MNDR | hsa-miR-33a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-41642 |
| MNDR | hsa-miR-33a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-41643 |
| MNDR | hsa-miR-33a-5p | Breast cancer luminal | MNDR-E-MI-41644 |
| MNDR | hsa-miR-33a-5p | Dermatomyositis | MNDR-E-MI-41645 |
| MNDR | hsa-miR-33a-5p | Prostate cancer | MNDR-E-MI-41646 |
| MNDR | hsa-miR-33a-5p | B-cell chronic lymphocytic leukemia | MNDR-E-MI-41647 |
| MNDR | hsa-miR-33a-5p | Gastric cancer | MNDR-E-MI-41648 |
| MNDR | hsa-miR-33a-5p | Gastric lymphoma | MNDR-E-MI-41649 |
| MNDR | hsa-miR-33a-5p | Alzheimer disease | MNDR-E-MI-41650 |
| MNDR | hsa-miR-33a-5p | Japanese encephalitis | MNDR-E-MI-41651 |
| MNDR | hsa-miR-33a-5p | Myotonic dystrophy | MNDR-E-MI-41652 |
| MNDR | hsa-miR-33a-5p | Head and neck cancer | MNDR-E-MI-41653 |
| MNDR | hsa-miR-33a-5p | Huntington disease | MNDR-E-MI-41654 |
| MNDR | hsa-miR-33a-5p | Chorea | MNDR-E-MI-41655 |
| MNDR | hsa-miR-33a-5p | Cardiovascular disease | MNDR-E-MI-41656 |
| MNDR | hsa-miR-33a-5p | Lung cancer | MNDR-E-MI-41657 |
| MNDR | hsa-miR-33a-5p | Parkinson disease | MNDR-E-MI-41658 |
| MNDR | hsa-miR-33a-5p | Basal-like breast cancer | MNDR-E-MI-41659 |
| MNDR | hsa-miR-33a-5p | Pancreatic cancer | MNDR-E-MI-41660 |
| MNDR | hsa-miR-33a-5p | Hepatitis C | MNDR-E-MI-41661 |
| MNDR | hsa-miR-33a-5p | Melanoma | MNDR-E-MI-41662 |
| MNDR | hsa-miR-33a-5p | Atherosclerosis | MNDR-E-MI-41663 |
| MNDR | hsa-miR-33a-5p | Rectum adenocarcinoma | MNDR-E-MI-41664 |
| MNDR | hsa-miR-33a-5p | Nephroblastoma | MNDR-E-MI-41665 |
| MNDR | hsa-miR-33a-5p | Colon cancer | MNDR-E-MI-41666 |
| MNDR | hsa-miR-33a-5p | Colon adenocarcinoma | MNDR-E-MI-41667 |
| MNDR | hsa-miR-33a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-41668 |
| MNDR | hsa-miR-33a-5p | Familial ovarian cancer | MNDR-E-MI-41669 |
| MNDR | hsa-miR-33a-5p | Prostate adenocarcinoma | MNDR-E-MI-41670 |
| MNDR | hsa-miR-33a-5p | Carcinoma ductal breast | MNDR-E-MI-41671 |
| MNDR | hsa-miR-33a-5p | Glioblastoma | MNDR-E-MI-41672 |
| MNDR | hsa-miR-33a-5p | Glioma | MNDR-E-MI-41673 |
| MNDR | hsa-miR-33a-5p | Hyperlipoproteinemia type iii | MNDR-E-MI-41674 |
| MNDR | hsa-miR-33a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-41675 |
| MNDR | hsa-miR-33a-5p | Osteosarcoma | MNDR-E-MI-41676 |
| MNDR | hsa-miR-33a-5p | Breast carcinoma | MNDR-E-MI-41677 |
| MNDR | hsa-miR-33a-5p | Uterine cancer | MNDR-E-MI-41678 |
| MNDR | hsa-miR-33a-5p | Cervical adenocarcinoma | MNDR-E-MI-41679 |
| MNDR | hsa-miR-33a-5p | Gastric adenocarcinoma | MNDR-E-MI-41680 |
| MNDR | hsa-miR-33a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-41681 |
| MNDR | hsa-miR-33a-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-41682 |
| MNDR | hsa-miR-33a-5p | Lung squamous cell carcinoma | MNDR-E-MI-41683 |
| MNDR | hsa-miR-33a-5p | Lung adenocarcinoma | MNDR-E-MI-41684 |
| MNDR | hsa-miR-33a-5p | Adrenocortical cancer | MNDR-E-MI-41685 |
| MNDR | hsa-miR-33a-5p | Bladder urothelial carcinoma | MNDR-E-MI-41686 |
| MNDR | hsa-miR-33a-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-41687 |
| MNDR | hsa-miR-33a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-41688 |
| MNDR | hsa-miR-33a-5p | Renal clear cell carcinoma | MNDR-E-MI-41689 |
| MNDR | hsa-miR-33a-5p | Esophageal cancer | MNDR-E-MI-41690 |
| MNDR | hsa-miR-33a-5p | Liver cirrhosis | MNDR-E-MI-41691 |
| MNDR | hsa-miR-33a-5p | Synovial sarcoma | MNDR-E-MI-41692 |
| MNDR | hsa-miR-33a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-41693 |
| MNDR | hsa-miR-33a-5p | Fibromyalgia | MNDR-E-MI-41694 |
| MNDR | hsa-miR-33a-5p | Breast invasive carcinoma | MNDR-E-MI-41695 |
| MNDR | hsa-miR-33a-5p | Hepatocellular carcinoma | MNDR-E-MI-41696 |
| MNDR | hsa-miR-33a-5p | Familiar ovarian carcinoma | MNDR-E-MI-41697 |
| MNDR | hsa-miR-33a-5p | B-cell lymphoma | MNDR-E-MI-41698 |
| MNDR | hsa-miR-33a-5p | T-cell leukemia | MNDR-E-MI-41699 |
| MNDR | hsa-miR-33a-5p | Malignant pleural mesothelioma | MNDR-E-MI-41700 |
| MNDR | hsa-miR-33a-5p | Barrett's adenocarcinoma | MNDR-E-MI-41701 |
| MNDR | hsa-miR-33a-5p | Hodgkin lymphoma | MNDR-E-MI-41702 |
| MNDR | hsa-miR-33a-5p | Burkitt lymphoma | MNDR-E-MI-41703 |
| MNDR | hsa-miR-33a-5p | Skin cutaneous melanoma | MNDR-E-MI-41704 |
| MNDR | hsa-miR-33a-5p | Skin melanoma | MNDR-E-MI-41705 |
| MNDR | hsa-miR-33a-5p | Acute myelogenous leukemia | MNDR-E-MI-41706 |
| MNDR | hsa-miR-33a-5p | Colorectal cancer | MNDR-E-MI-41707 |
| MNDR | hsa-miR-33a-5p | Multiple myeloma | MNDR-E-MI-41708 |
| MNDR | hsa-miR-33a-5p | Prostatic neoplasms | MNDR-E-MI-41709 |
| MNDR | hsa-miR-33a-5p | Epstein-barr virus infections | MNDR-E-MI-41710 |
| MNDR | hsa-miR-33a-5p | Stroke lacunar | MNDR-E-MI-41711 |
| MNDR | hsa-miR-33a-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-41712 |
| MNDR | hsa-miR-33a-5p | Barrett's carcinogenesis | MNDR-E-MI-41713 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022115 |
TOP